Preclinical applications of resting-state functional magnetic resonance imaging (rsfMRI) offer
the possibility to non-invasively probe whole-brain network dynamics and to investigate the …

Background Exposure to maternal immune activation (MIA) in utero is a risk factor for
neurodevelopmental disorders later in life. The impact of the gestational timing of MIA exposure on …

Obesity is recognized as a significant risk factor for Alzheimer's disease (AD). Studies have
supported that obesity accelerates AD-related pathophysiology and memory impairment in …

Dysregulation of habit formation has been recently proposed as pivotal to eating disorders.
Here, we report that a subset of patients suffering from restrictive anorexia nervosa have …

Central to the malignant behaviour that endows cancer cells with growth advantage is their
unique metabolism. Cancer cells can process nutrient molecules differently from normal cells …

The predominantly pre-synaptic intrinsically disordered protein α-synuclein is prone to
misfolding and aggregation in synucleinopathies, such as Parkinson’s disease (PD) and …

Prenatal exposure to maternal immune activation (MIA) and chronic adolescent cannabis
use are both risk factors for neuropsychiatric disorders. However, exposure to a single risk …

Animal models of Alzheimer’s disease (AD) can be used to determine the progressive
neurodegeneration characteristics of AD in vivo using magnetic resonance imaging (MRI). Given …

Following its success in the treatment of refractory movement disorders, deep brain
stimulation (DBS) is currently under clinical investigation as a possible treatment for several …

Our current understanding of litter variability in neurodevelopmental studies using mice may
limit translation of neuroscientific findings. Higher variance of measures across litters than …